Legislation
   Alaska
   Naturopathic State Laws
   Response to the "OAND"
   Washington Legislation

Journal of the American Naturopathic Medical Association (JANMA)
   Vol. 12 No. 2   07/08    NEW  !
   Vol. 11 No. 3   10/07
   Vol. 11 No. 2   06/07
   Vol. 11 No. 1   02/07
   Vol. 10 No. 4   11/06
   Vol. 10 No. 3   07/06
   Vol. 10 No. 2   04/06
   Vol. 10 No. 1   01/06
   Vol. 9 No. 3     10/05
   Vol. 9 No. 2     07/05
   Vol. 9 No. 1     04/05
   Vol. 8 No. 4     12/04
   Vol. 8 No. 2     07/04
   Vol. 8 No. 1     03/04
   Vol. 7 No. 4     12/03
   Vol. 7 No. 3     09/03
   Vol. 7 No. 2     06/03
   Vol. 7 No. 1     04/03
   Vol. 6 No. 4
   Vol. 6 No. 3
   Vol. 6 No. 2
   Vol. 6 No. 1
   Vol. 5 No. 4
   Vol. 5 No. 3
   Vol. 5 No. 2
   Vol. 5 No. 1
   Vol. 4 No. 4
   Vol. 4 No. 3
   Vol. 4 No. 2
   Vol. 4 No. 1

Facts
   History & Demise of CNME
   CNME Bites The Dust!
   Caution Nat. Med. Edu.
   Naturopaths In Denial
   Fraud?
   NH Gov. Cavalier Response
   Ltr. to AANP From NH Leg.
   NCNM Student Remarks:
       Merry Bern Letter
       Stephen Sporn
   NCNM Student Report
   Media
   Canada
   Response to the "OAND"
   Naturopathic Lawsuits
       Lawsuit #1
       Lawsuit #2
   Licensing Vs. Certification 

[1] Traber MG. Vitamin E. In Modern Nutrition in Health and Disease, 9th ed. William & Wilkins, Balt.,1999:347-362

[2] Whitney EN, Hamilton EMN. Understanding Nutrition, 4ed. West Publishing, New York, 1987

[3] Schelling GT, Roeder RA, Garber MJ, Pumfrey WM. Bioavailability and interaction of vitamin A and vitamin E in ruminants. J Nutr,1995;125(6):1799S-1803S

[4] Farrell PA, Roberts RJ. Vitamin E. In Modern Nutrition in Health and Disease, 8th ed. Lea & Febiger, Phil.,1994:326-358

[5] The natural and synthetic forms of vitamin E deliver equal health benefits to human beings. J Am Diet Assoc, 1998;98(5):522

[6] Devaraj S, Adams-Huet B, Fuller CJ, Jialal I. Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha tocopherol on LDL oxidation. Arterioscler Thromb Vasc Biol, 1997;17:2273-2279

[7] Transport of alpha-tocopherol during pregnancy. J Am Diet Assoc, 1998;98(8):918

[8] Traber MG, et al. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism. J Lipid Res, 1992;33:1171-1182

[9] An Overview of Vitamin E Efficacy. VERIS Research Information Service, November 1998

[10] Burton GW, et al. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr, 1998;67(4):669-684

[11] Acuff RV, Dunworth RG, Webb LW, Lane JR. Transport of deuterium-labeled tocopherols during pregnancy. Am J Clin Nutr, 1998;67:459-464

[12] Traber MG, Elsner A, Brigelius-Flohe R. Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopherol acetates. FEBS Letters, 1998;437:145-148

[13] Vinson J, Bose P, Lemoine L, Hsiao KH. Bioavailability studies. In Nutrient Availability: Chemical and Biological Aspects. Royal Society of Chemistry, Cambridge (UK) 1989:125-127

[14] Nitta Y, et al. Induction of transplantable tumors by repeated injections of natural and synthetic vitamin E in mice and rats. Jpn J Cancer Res, 1991;82(5):511-517

[15] Mervyn L. The B Vitamins. Thorsons, Wellingborough (UK), 1981

[16] The United States Pharmacopeial Convention. USAN and USP Dictionary of Drug Names. Mack Printing, Easton (PA),1986

[17] Macrae R, Robson RK, Sadler MJ. Encyclopedia of Food Science and Nutrition. Academic Press, New York, 1993

[18] Kennedy E. The 1995 USDA/HHS Dietary Guidelines - An Overview. USDA, Washington, D.C.,1995

Comparative Study of Hormone Replacement
Including Transdermal and Oral Bio-Identical Natural Hormones and Homeopathic Hormone Stimulation and Rejuvenation Using Salivary Testing as a Diagnostic Tool.

By: Theresa Dale, Ph.D., N.D.

1. Orth DN, Kovaks WJ, DeBold CR: The adrenal cortex. William's Textbook of Endocrinology, 8th ed. Wilson JD, Foster DW, Eds. WB Saunders Co, Philadelphia, 1992, p 489

2. Meikle AW, Daynes RA, Araneo BA: Adrenal androgen secretion and biologic effects. Endocrinol Metab Clin North Am 20:381, 1991 [ 1831756

3. Quinn SJ, Williams GH: Regulation of aldosterone secretion. Ann Rev Physiol 50:409, 1988

4. Orth DN: Corticotropin-releasing hormone in humans. Endocr Rev 13:164, 1992

5. Watabe T, Tanaka K, Kumagae M, et al: Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man. J Clin Endocrinol Metab 66:1132, 1988 [ 2836468]

6. Salata RA, Jarrett DB, Verbalis JG, et al: Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. J Clin Invest 81:766, 1988 [ 2830315

7. Iranmanesh A, Lizarralde G, Short D, et al: Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. J Clin Endocrinol Metab 71:1276, 1990

8. Dallman MF, Akana SF, Levin N, et al: Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann NY Acad Sci 746:22, 1994 F 7825879

9. Findling JW, Engeland WC, Raff H: The use of immunoradiometric assay for the measurement of ACTH in human plasma. Trends in Endocrinol Metab 1:283, 1990

10. Kaye TB, Crapo L: The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112:434,1990

11. Kannan CR: Diseases of the adrenal cortex. DM 34:613, 1988

12. Seeler LR: Cushing's syndrome. Cleve Clin J Med 55:329,1988

13. Biller BMK, Alexander JM, Zervas NT, et al: Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab 75:1303, 1992

14. Odell WD: Ectopic ACTH secretion: a misnomer. Endocrinol Metab Clin North Am 20:371, 1991

15. Ulick S, Wang JZ, Blumenfeld JD, et al: Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 74:963, 1992 1569172

16. Williams GH: Guardian of the gate: receptors, enzymes, and mineralocorticoid function (editorial). J Clin Endocrinol Metab 74:961, 1992

17. Belsky JL, Cuello B, Swanson LW, et al: Cushing's syndrome due to ectopic production of corticotropin-releasing factor. J Clin Endocrinol Metab 60:496, 1985 [ 2982899

18. King DR, Lack EE: Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 44:239, 1979 [ 455249

19. Malchoff CD, MacGillivray D, Malchoff DM: Adrenocorticotropic hormoneindependent adrenal hyperplasia. Endocrinologist 6:79, 1996

20. Hermus AR, Pieters GF, Smals AG, et al: Transition from pituitarydependent to adrenal-dependent Cushing's syndrome. N Engl J Med 318:966,1988

21. Young WF Jr, Carney JA, Musa BU, et al: Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease: reinvestigation 50 years later. N Engl J Med 321:1659, 1989

22. Reznik Y, Allali-Zerah V, Chayvialle JA, et al: Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 327:981, 1992

23. Lacroix A, Bolte E, Tremblay J, et al: Gastric inhibitory polypeptide-dependent cortisol hypersecretion-a new cause of Cushing's syndrome. N Engl J Med 327:974, 1992

24. Bertagna X: New causes of Cushing's syndrome (editorial). N Engi J Med 327:1024,1992

25. Kreisberg R: Half a loaf. N Engl J Med 330:1295, 1994

26. Findling JW: Clinical application of a new immunoradiometric assay for ACTH. Endocrinologist 2:360, 1992

27. Snow K: Biochemical evaluation of adrenal dysfunction: the laboratory perspective. Mayo Clin Proc 67:1055, 1992

28. Flack MR, Oldfield EH, Cutler GB Jr, et al: Urine free cortisol in the highdose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 116:211, 1992

29. Zarate A, Kovaks K, Flores M, et al: ACTH and CRF-producing bron chial carcinoid associated with Cushing's syndrome. Clin Endocrinol 24:523, 1986

30. Grossman AB, Howlett TA, Perry L, et al: CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol 29:167, 1988

31. Nieman LK, Cutler GB Jr, Oldfield EH, et al: The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease. J Clin Endocrinol Metab 69:165, 1989

32. Schulte HM, Allolio B, Gunther TK et al: Bilateral and simultaneous sinus petrosus inferior catheterization in patients with Cushing's syndrome: plasma-immunoreactive-ACTH-concentrations before and after administration of CRF. Horm Metab Res (suppl) 16:66, 1987

33. Loriaux DL, Nieman L: Corticotropin-releasing hormone testing in pituitary disease. Endocrinol Metab Clin North Am 20:363, 1991

34. Malchoff CD, Orth DN, Abboud C, et al: Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Am J Med 84:760, 1988

35. Gold PW, Loriaux DL, Roy A, et al: Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 314:1329,1986

36. Groote Veldman R, Meinders AE: On the mechanism of alcohol-induced pseudo-Cushing's syndrome. Endocr Rev 17:262, 1996

37. Prevalence of 3-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess, American Journal of Obstetrics and Gynecology September 1999 - Volume 181 - Number 3 Carlos Moran, MD, MS, H. Downing Potter, BS, Rosario Reyna, BS, d, Larry R. Boots, PhD, Ricardo Azziz, MD, MPH.

38. 1: 3 Nutr 2001 May; 131(5):1621S-5S Human saliva as a diagnostic specimen. Hofman LF. Saliva Testing and Reference Laboratory, Inc., Seattle, WA 98104. PMID: 11340128 [PubMed - in process)

39. 1: Endocr Res 2000 Nov;26(4):489-504 Fetal hypothalamic-pituitary adrenal (HPA) development and activation as a determinant of the timing of birth, and of postnatal disease. Challis 3, Sloboda D, Matthews S, Holloway A, Alfaidy N, Howe D, Fraser M, Newnham 1. Department of Physiology, University of Toronto, Ontario, Canada. PMID: 11196419 [PubMed - indexed for MEDLINE]

40. Van Goozen SH, Weigant VM, Endert E, Helmond FA, Van de Poll NE. Psychoendocrinological assessment of the menstrual cycle: the relationship between hor-mones, sexuality, and mood. Arch Sex Behav 1997;26(4):359-382.

41. Lee KA, Shaver JF, Giblin EC, Woods NF. Sleep patterns related to menstrual cycle phase and premenstrual affective symptoms. Sleep 1990; 13(5):403-409.

42. Dye L, Blundell JE. Menstrual cycle and appetite control: implications for weight regu-lation. Hum Reprod 1997;12(6):1142-1151.

43. Redei E, Freeman EW. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinol 1995; 20(30):259-267.

44. Berthonneu 3, Tanguy G, Janssens Y, Guichard A, Boyer P, Zorn JR, Cedard L. Salivary oestra-diol in spontaneous and stimulated menstrual cycles. Hum Rep 1989;4:625-28.

45. De Boever 1, Kohen F, Bouve 1, Leyseele D,Vandekerckhove D. Direct chemilumines-cence immunoassay of estradiol in saliva. Clin Chem1990;36:2036-41.

46. Wong Y, Mao K, Panesar NS, Loong EP, Chang AM, Mi ZJ. Salivary estradiol and prog-esterone during the normal ovulatory menstru-al cycle in Chinese women. Eur I Obst Gynecol and Rep Biol 1990;34:129-35.

47. Vining R, McGinley R, and Symons R. Hormones in saliva: mode of entry and conse-quent implications for clinical interpretation. Clin Chem 1983;29:1752-56.

48. Bhagavan NV. Medical Biochemistry. Boston: Jones and Bartlett Publishers; 1992, 805-807.

49. Vuorento T, Lahti A, Hovatta O, and Huhtaniemi I. Daily measurements of salivary progesterone reveal a high rate of anovulation in healthy students. Scan I Clin Lab Invest 1989;49:395-401.

50. Danutra V, Turkes A, Read G, Wilson D, Griffiths V, Jones R, Griffiths K. Progesterone concentrations in samples of saliva from ado-lescent girls living in Britain and Thailand, two countries where women are at widely differing risk of breast cancer. I Endocrin 1988; 121:375-81.

51. Finn M, Gosling 3, Tallon D, Joyce L, Meehan F, Fottrell P. Follicular growth and corpus luteum function in women with unexplained infertility, monitored by ultrasonography and measurement of daily progesterone. Gynecol Endocrin 1989;3:297-308.

52. Vuorento T, Hovatta 0, Kurunmaki H, Ratsula K, Huhtaneimi I. Measurements of salivary progesterone throughout the menstrual cycle in women suffering from unexplained infertility reveal high frequency of luteal phase defects. Fertil Steril 1990;54:211-16.

53. Vuorento T, and Huhtaniemi I. Daily measure-ments of salivary progesterone during men-strual cycle in adolescent girls. Fertil Steril 1992;58:685-90.

54. Wren B. Reproductive endocrinology. In: Hacker N and Moore I., editors. Essentials of obstetrics and gynecology. Philadelphia: W. B. Sanders Co., 1992.

55. Ronkainen H, et al. Physical exercise- induced changes and seasonassociated differences in the pituitary-ovarian function of runners and joggers. 3 Clin Endocrin Metab 1985;60:416.

56. Lipson S and Ellison P. Normative study of age variation in salivary progesterone profiles. 3 Biosoc Sci 1992;24:233-44.

57. Hamilton C, Wetzels L, Evers 1, Hoogland H, Muijtjens A, de Haan 3. Follicle growth curves and hormonal patterns in patients with luteinized unruptured follicle syndrome. Fertil Steril 1985;43:541-48.

58. Van Zonneveld P, te Velde E, Koppeschaar H. Low luteal phase serum progesterone levels in regularly cycling women are predictive of subtle ovulating disorders. Gynecol Endocrin 1994;8:169-74.

59. Ayers J, Birenbuam DL, Menon KM. Luteal phase dysfunction in endometriosis: elevated progesterone levels in peripheral and ovarian veins during the follicular phase. Fertil Steril 1987;47:935-39.

60. Wingfield M, O'Herlihy C, Finn M, Tallon D, Fottrell P. Follicular and luteal phase salivary progesterone profiles in women with endometriosis and infertility. Gynecol Endocrin 1994;8:21-25.

61. Pirke KM, Schweiger U, Laessle R, Dickhaut B, Schweiger M, Waechtler M. Dieting influences the menstrual cycle: vegetarian versus nonvegetarian diet. Fertil Steril 1986;46:1083.

62. Karmen B. Hormone replacement therapy: yes or no? Novato, CA: Nutrition Counter, Inc., 1993.

63. Wilson D, Turkes A, ]ones R, Danutra V, Read G, Griffiths K. A comparison of menstrual cycle profiles of salivary progesterone in British and Thai adolescent girls. Eur I Cancer 1992; 28A: 1162-67.

64. De Cree C, Lewin R, Ostyn M. The monitoring of the menstrual status of female athletes by salivary steroid determination and ultrasonography. Eur 3 App Physiol 1990;60:472-77.

65. Keizer H. Exercise- and training-induced men-strual cycle irregularities (AMI). Int I Sports Med 1986;8(suppl 3):137-74.

66. Keizer H, Poortman 3, Bunnick G. Influence of physical exercise on sex steroid metabolism. J Appl Physiol 1980;48:765-69.